NRF2 and the Hallmarks of Cancer

Cancer Cell

Volumn 34, Issue 1, 2018, Pages 21-43

  Rojo de la Vega, Montserrat ^a   Chapman, Eli ^a   Zhang, Donna D ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

antioxidant response element (ARE); cancer initiation and progression; carcinogenesis; chemoresistance; KEAP1; metabolic reprogramming; metastasis; NRF2; oxidative stress

Indexed keywords

TELOMERASE; TRANSCRIPTION FACTOR NRF2; TUMOR SUPPRESSOR PROTEIN; NFE2L2 PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CANCER RESISTANCE; CARCINOGENESIS; CELL FUNCTION; CELL METABOLISM; GENE EXPRESSION; GENOMIC INSTABILITY; HOMEOSTASIS; HUMAN; IMMUNOSURVEILLANCE; INFLAMMATION; MALIGNANT NEOPLASM; METASTASIS; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION REACTION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR PROMOTION; ANIMAL; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 85045005779     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.03.022     Document Type: Review

References (339)

1. Agyeman, A.S., Chaerkady, R., Shaw, P.G., Davidson, N.E., Visvanathan, K., Pandey, A., Kensler, T.W., Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat. 132 (2012), 175–187.
2. Alexandre, J., Hu, Y., Lu, W., Pelicano, H., Huang, P., Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res. 67 (2007), 3512–3517.
3. Alnouti, Y., Klaassen, C.D., Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci. 101 (2008), 51–64.
4. Altman, B.J., Stine, Z.E., Dang, C.V., From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16 (2016), 619–634.
5. Anckar, J., Sistonen, L., Regulation of HSF1 function in the heat stress response: implications in aging and disease. Annu. Rev. Biochem. 80 (2011), 1089–1115.
6. Andrews, B.J., Lehman, J.A., Turchi, J.J., Kinetic analysis of the Ku-DNA binding activity reveals a redox-dependent alteration in protein structure that stimulates dissociation of the Ku-DNA complex. J. Biol. Chem. 281 (2006), 13596–13603.
7. Anedda, A., Lopez-Bernardo, E., Acosta-Iborra, B., Saadeh Suleiman, M., Landazuri, M.O., Cadenas, S., The transcription factor Nrf2 promotes survival by enhancing the expression of uncoupling protein 3 under conditions of oxidative stress. Free Radic. Biol. Med. 61C (2013), 395–407.
8. Ann, E.J., Kim, M.Y., Yoon, J.H., Ahn, J.S., Jo, E.H., Lee, H.J., Lee, H.W., Kang, H.G., Choi, D.W., Chun, K.H., et al. Tumor suppressor HIPK2 regulates malignant growth via phosphorylation of Notch1. Cancer Res. 76 (2016), 4728–4740.
9. Arfmann-Knubel, S., Struck, B., Genrich, G., Helm, O., Sipos, B., Sebens, S., Schafer, H., The crosstalk between Nrf2 and TGF-beta1 in the epithelial-mesenchymal transition of pancreatic duct epithelial cells. PLoS One, 10, 2015, e0132978.
10. Arlt, A., Bauer, I., Schafmayer, C., Tepel, J., Muerkoster, S.S., Brosch, M., Roder, C., Kalthoff, H., Hampe, J., Moyer, M.P., et al. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene 28 (2009), 3983–3996.
11. Athale, J., Ulrich, A., MacGarvey, N.C., Bartz, R.R., Welty-Wolf, K.E., Suliman, H.B., Piantadosi, C.A., Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic. Biol. Med. 53 (2012), 1584–1594.
12. auf dem Keller, U., Huber, M., Beyer, T.A., Kumin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D.A., Johnson, J.A., et al. Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol. Cell. Biol. 26 (2006), 3773–3784.
13. Aydin, Y., Chedid, M., Chava, S., Danielle Williams, D., Liu, S., Hagedorn, C.H., Sumitran-Holgersson, S., Reiss, K., Moroz, K., Lu, H., et al. Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Sci. Rep., 7, 2017, 9223.
14. B'chir, W., Maurin, A.C., Carraro, V., Averous, J., Jousse, C., Muranishi, Y., Parry, L., Stepien, G., Fafournoux, P., Bruhat, A., The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 41 (2013), 7683–7699.
15. Bae, I., Fan, S., Meng, Q., Rih, J.K., Kim, H.J., Kang, H.J., Xu, J., Goldberg, I.D., Jaiswal, A.K., Rosen, E.M., BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res. 64 (2004), 7893–7909.
16. Baenke, F., Peck, B., Miess, H., Schulze, A., Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis. Model. Mech. 6 (2013), 1353–1363.
17. Baird, L., Lleres, D., Swift, S., Dinkova-Kostova, A.T., Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. USA 110 (2013), 15259–15264.
18. Barrott, J.J., Haystead, T.A., Hsp90, an unlikely ally in the war on cancer. FEBS J. 280 (2013), 1381–1396.
19. Bataille, A.M., Manautou, J.E., Nrf2: a potential target for new therapeutics in liver disease. Clin. Pharmacol. Ther. 92 (2012), 340–348.
20. Bauer, A.K., Cho, H.Y., Miller-Degraff, L., Walker, C., Helms, K., Fostel, J., Yamamoto, M., Kleeberger, S.R., Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS One, 6, 2011, e26590.
21. Bauvois, B., New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta 1825 (2012), 29–36.
22. Bennett, S.M., Neher, T.M., Shatilla, A., Turchi, J.J., Molecular analysis of Ku redox regulation. BMC Mol. Biol., 10, 2009, 86.
23. Berndtsson, M., Hagg, M., Panaretakis, T., Havelka, A.M., Shoshan, M.C., Linder, S., Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int. J. Cancer 120 (2007), 175–180.
24. Boucher, J., Kleinridders, A., Kahn, C.R., Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol., 6, 2014, 10.1101/cshperspect.a009191.
25. Brandl, A., Hartmann, A., Bechmann, V., Graf, B., Nerlich, M., Angele, P., Oxidative stress induces senescence in chondrocytes. J. Orthop. Res. 29 (2011), 1114–1120.
26. Bukau, B., Weissman, J., Horwich, A., Molecular chaperones and protein quality control. Cell 125 (2006), 443–451.
27. Cabello, C.M., Bair, W.B. 3rd, Wondrak, G.T., Experimental therapeutics: targeting the redox Achilles heel of cancer. Curr. Opin. Investig. Drugs 8 (2007), 1022–1037.
28. Cairns, R.A., Harris, I.S., Mak, T.W., Regulation of cancer cell metabolism. Nat. Rev. Cancer 11 (2011), 85–95.
29. Carracedo, A., Cantley, L.C., Pandolfi, P.P., Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 13 (2013), 227–232.
30. Chandel, N.S., McClintock, D.S., Feliciano, C.E., Wood, T.M., Melendez, J.A., Rodriguez, A.M., Schumacker, P.T., Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275 (2000), 25130–25138.
31. Chen, H.Y., White, E., Role of autophagy in cancer prevention. Cancer Prev. Res. (Phila.) 4 (2011), 973–983.
32. Chen, W., Jiang, T., Wang, H., Tao, S., Lau, A., Fang, D., Zhang, D.D., Does Nrf2 contribute to p53-mediated control of cell survival and death?. Antioxid. Redox Signal. 17 (2012), 1670–1675.
33. Chen, W., Sun, Z., Wang, X.J., Jiang, T., Huang, Z., Fang, D., Zhang, D.D., Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell 34 (2009), 663–673.
34. Chio, I.I., Jafarnejad, S.M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Ohlund, D., et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166 (2016), 963–976.
35. Chondrogianni, N., Stratford, F.L., Trougakos, I.P., Friguet, B., Rivett, A.J., Gonos, E.S., Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278 (2003), 28026–28037.
36. Chondrogianni, N., Tzavelas, C., Pemberton, A.J., Nezis, I.P., Rivett, A.J., Gonos, E.S., Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J. Biol. Chem. 280 (2005), 11840–11850.
37. Chorley, B.N., Campbell, M.R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S.R., Bell, D.A., Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 40 (2012), 7416–7429.
38. Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., Hayes, J.D., Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32 (2013), 3765–3781.
39. Cipolla, C.M., Lodhi, I.J., Peroxisomal dysfunction in age-related diseases. Trends Endocrinol. Metab. 28 (2017), 297–308.
40. Collado, M., Serrano, M., Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 10 (2010), 51–57.
41. Cong, Z.X., Wang, H.D., Zhou, Y., Wang, J.W., Pan, H., Zhang, D.D., Zhang, L., Zhu, L., Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells. J. Neurooncol. 116 (2013), 41–48.
42. Cooke, M.S., Evans, M.D., Dizdaroglu, M., Lunec, J., Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17 (2003), 1195–1214.
43. Crawford, L.J., Walker, B., Irvine, A.E., Proteasome inhibitors in cancer therapy. J. Cell Commun. Signal. 5 (2011), 101–110.
44. Cullinan, S.B., Diehl, J.A., Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 38 (2006), 317–332.
45. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., del Sal, G., et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4 (2002), 11–19.
46. Das, U., Manna, K., Khan, A., Sinha, M., Biswas, S., Sengupta, A., Chakraborty, A., Dey, S., Ferulic acid (FA) abrogates gamma-radiation induced oxidative stress and DNA damage by up-regulating nuclear translocation of Nrf2 and activation of NHEJ pathway. Free Radic. Res. 51 (2017), 47–63.
47. David, S.S., O'Shea, V.L., Kundu, S., Base-excision repair of oxidative DNA damage. Nature 447 (2007), 941–950.
48. Dayalan Naidu, S., Dinkova-Kostova, A.T., Regulation of the mammalian heat shock factor 1. FEBS J. 284 (2017), 1606–1627.
49. Dayalan Naidu, S., Kostov, R.V., Dinkova-Kostova, A.T., Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection. Trends Pharmacol. Sci. 36 (2015), 6–14.
50. De Marco, F., Bucaj, E., Foppoli, C., Fiorini, A., Blarzino, C., Filipi, K., Giorgi, A., Schinina, M.E., di Domenico, F., Coccia, R., et al. Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One, 7, 2012, e34366.
51. DeNardo, D.G., Andreu, P., Coussens, L.M., Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 29 (2010), 309–316.
52. DeNicola, G.M., Chen, P.H., Mullarky, E., Sudderth, J.A., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J.M., Huffman, K.E., et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat. Genet. 47 (2015), 1475–1481.
53. DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K.H., Yeo, C.J., Calhoun, E.S., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475 (2011), 106–109.
54. Dhenaut, A., Boiteux, S., Radicella, J.P., Characterization of the hOGG1 promoter and its expression during the cell cycle. Mutat. Res. 461 (2000), 109–118.
55. Diehn, M., Cho, R.W., Lobo, N.A., Kalisky, T., Dorie, M.J., Kulp, A.N., Qian, D., Lam, J.S., Ailles, L.E., Wong, M., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458 (2009), 780–783.
56. Dinkova-Kostova, A.T., Abramov, A.Y., The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 88 (2015), 179–188.
57. Dobler, D., Ahmed, N., Song, L., Eboigbodin, K.E., Thornalley, P.J., Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 55 (2006), 1961–1969.
58. Donnelly, N., Storchova, Z., Aneuploidy and proteotoxic stress in cancer. Mol. Cell. Oncol., 2, 2015, e976491.
59. Fan, C.H., Liu, W.L., Cao, H., Wen, C., Chen, L., Jiang, G., O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis., 4, 2013, e876.
60. Fan, Z., Wirth, A.K., Chen, D., Wruck, C.J., Rauh, M., Buchfelder, M., Savaskan, N., Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis, 6, 2017, e371.
61. Faraonio, R., Vergara, P., di Marzo, D., Pierantoni, M.G., Napolitano, M., Russo, T., Cimino, F., p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J. Biol. Chem. 281 (2006), 39776–39784.
62. Finkel, T., Signal transduction by reactive oxygen species. J. Cell Biol. 194 (2011), 7–15.
63. Fribley, A., Zeng, Q., Wang, C.Y., Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol. Cell. Biol 24 (2004), 9695–9704.
64. Frohlich, D.A., McCabe, M.T., Arnold, R.S., Day, M.L., The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 27 (2008), 4353–4362.
65. Fung, C., Lock, R., Gao, S., Salas, E., Debnath, J., Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 19 (2008), 797–806.
66. Gabriel, D., Roedl, D., Gordon, L.B., Djabali, K., Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. Aging Cell 14 (2015), 78–91.
67. Gacesa, R., Dunlap, W.C., Barlow, D.J., Laskowski, R.A., Long, P.F., Rising levels of atmospheric oxygen and evolution of Nrf2. Sci. Rep., 6, 2016, 27740.
68. Gajewski, T.F., Schreiber, H., Fu, Y.X., Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14 (2013), 1014–1022.
69. Galluzzi, L., Pietrocola, F., Bravo-San Pedro, J.M., Amaravadi, R.K., Baehrecke, E.H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D.A., Karantza, V., et al. Autophagy in malignant transformation and cancer progression. EMBO J. 34 (2015), 856–880.
70. Gameiro, I., Michalska, P., Tenti, G., Cores, A., Buendia, I., Rojo, A.I., Georgakopoulos, N.D., Hernandez-Guijo, J.M., Teresa Ramos, M., Wells, G., et al. Discovery of the first dual GSK3beta inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease. Sci. Rep., 7, 2017, 45701.
71. Gorrini, C., Baniasadi, P.S., Harris, I.S., Silvester, J., Inoue, S., Snow, B., Joshi, P.A., Wakeham, A., Molyneux, S.D., Martin, B., et al. BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J. Exp. Med. 210 (2013), 1529–1544.
72. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12 (2013), 931–947.
73. Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25 (2011), 460–470.
74. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S.C., Kamphorst, J.J., Strohecker, A.M., Chen, G., Price, S., Lu, W., Teng, X., et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 27 (2013), 1447–1461.
75. Guo, J.Y., White, E., Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors. Autophagy 9 (2013), 1636–1638.
76. Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100 (2000), 57–70.
77. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
78. Harder, B., Jiang, T., Wu, T., Tao, S., Rojo de la Vega, M., Tian, W., Chapman, E., Zhang, D.D., Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochem. Soc. Trans. 43 (2015), 680–686.
79. Harding, H.P., Zhang, Y., Zeng, H., Novoa, I., Lu, P.D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11 (2003), 619–633.
80. Hayes, J.D., Dinkova-Kostova, A.T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39 (2014), 199–218.
81. He, C.H., Gong, P., Hu, B., Stewart, D., Choi, M.E., Choi, A.M., Alam, J., Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem. 276 (2001), 20858–20865.
82. Heiss, E.H., Schachner, D., Zimmermann, K., Dirsch, V.M., Glucose availability is a decisive factor for Nrf2-mediated gene expression. Redox Biol. 1 (2013), 359–365.
83. Helleday, T., Petermann, E., Lundin, C., Hodgson, B., Sharma, R.A., DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer 8 (2008), 193–204.
84. Hiramoto, K., Satoh, H., Suzuki, T., Moriguchi, T., Pi, J., Shimosegawa, T., Yamamoto, M., Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis. Cancer Prev. Res. (Phila.) 7 (2014), 835–844.
85. Hirota, A., Kawachi, Y., Itoh, K., Nakamura, Y., Xu, X., Banno, T., Takahashi, T., Yamamoto, M., Otsuka, F., Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis. J. Invest. Dermatol. 124 (2005), 825–832.
86. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., Yodoi, J., AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94 (1997), 3633–3638.
87. Hoetzenecker, W., Echtenacher, B., Guenova, E., Hoetzenecker, K., Woelbing, F., Bruck, J., Teske, A., Valtcheva, N., Fuchs, K., Kneilling, M., et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat. Med. 18 (2012), 128–134.
88. Hofmann, T.G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., Schmitz, M.L., Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4 (2002), 1–10.
89. Holmstrom, K.M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J.M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open 2 (2013), 761–770.
90. Holmstrom, K.M., Finkel, T., Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15 (2014), 411–421.
91. Homma, S., Ishii, Y., Morishima, Y., Yamadori, T., Matsuno, Y., Haraguchi, N., Kikuchi, N., Satoh, H., Sakamoto, T., Hizawa, N., et al. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 15 (2009), 3423–3432.
92. Hota, K.B., Hota, S.K., Chaurasia, O.P., Singh, S.B., Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 22 (2012), 723–736.
93. Hu, Y., Petit, S.A., Ficarro, S.B., Toomire, K.J., Xie, A., Lim, E., Cao, S.A., Park, E., Eck, M.J., Scully, R., et al. PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. Cancer Discov. 4 (2014), 1430–1447.
94. Huang, W.C., Li, X., Liu, J., Lin, J., Chung, L.W., Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol. Cancer Res. 10 (2012), 133–142.
95. Ichimura, Y., Waguri, S., Sou, Y.S., Kageyama, S., Hasegawa, J., Ishimura, R., Saito, T., Yang, Y., Kouno, T., Fukutomi, T., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51 (2013), 618–631.
96. Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A.E., Homma, S., Nomura, A., et al. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10 (2005), 1113–1125.
97. Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M., et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 193 (2011), 275–284.
98. Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19 (2011), 387–400.
99. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997), 313–322.
100. Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., Yamamoto, M., Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol. Cell. Biol 24 (2004), 36–45.
101. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., Yamamoto, M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13 (1999), 76–86.
102. Itoh, K., Ye, P., Matsumiya, T., Tanji, K., Ozaki, T., Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J. Clin. Biochem. Nutr. 56 (2015), 91–97.
103. Jang, J., Wang, Y., Kim, H.S., Lalli, M.A., Kosik, K.S., Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells. Stem Cells 32 (2014), 2616–2625.
104. Jaramillo, M.C., Zhang, D.D., The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 27 (2013), 2179–2191.
105. Jayakumar, S., Pal, D., Sandur, S.K., Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells. Mutat. Res. 779 (2015), 33–45.
106. Jeayeng, S., Wongkajornsilp, A., Slominski, A.T., Jirawatnotai, S., Sampattavanich, S., Panich, U., Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling. Free Radic. Biol. Med. 108 (2017), 918–928.
107. Jeong, Y., Hoang, N.T., Lovejoy, A., Stehr, H., Newman, A.M., Gentles, A.J., Kong, W., Truong, D., Martin, S., Chaudhuri, A., et al. Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance. Cancer Discov. 7 (2017), 86–101.
108. Ji, X., Wang, H., Zhu, J., Zhu, L., Pan, H., Li, W., Zhou, Y., Cong, Z., Yan, F., Chen, S., Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Int. J. Cancer 135 (2013), 574–584.
109. Jia, Y., Chen, J., Zhu, H., Jia, Z.H., Cui, M.H., Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes. Oncol. Rep. 34 (2015), 2296–2304.
110. Jiang, L., Shestov, A.A., Swain, P., Yang, C., Parker, S.J., Wang, Q.A., Terada, L.S., Adams, N.D., McCabe, M.T., Pietrak, B., et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532 (2016), 255–258.
111. Jiang, T., Harder, B., Rojo de la Vega, M., Wong, P.K., Chapman, E., Zhang, D.D., p62 links autophagy and Nrf2 signaling. Free Radic. Biol. Med. 88 (2015), 199–204.
112. Jodar, L., Mercken, E.M., Ariza, J., Younts, C., Gonzalez-Reyes, J.A., Alcain, F.J., Buron, I., de Cabo, R., Villalba, J.M., Genetic deletion of Nrf2 promotes immortalization and decreases life span of murine embryonic fibroblasts. J. Gerontol. A Biol. Sci. Med. Sci. 66 (2011), 247–256.
113. Johnson, D.A., Amirahmadi, S., Ward, C., Fabry, Z., Johnson, J.A., The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol. Sci. 114 (2010), 237–246.
114. Johnson, D.E., The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. Endocr. Relat. Cancer 22 (2015), T1–T17.
115. Jowsey, I.R., Jiang, Q., Itoh, K., Yamamoto, M., Hayes, J.D., Expression of the aflatoxin B1-8,9-epoxide-metabolizing murine glutathione S-transferase A3 subunit is regulated by the Nrf2 transcription factor through an antioxidant response element. Mol. Pharmacol. 64 (2003), 1018–1028.
116. Kanlaya, R., Khamchun, S., Kapincharanon, C., Thongboonkerd, V., Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells. Sci. Rep., 6, 2016, 30233.
117. Kansanen, E., Bonacci, G., Schopfer, F.J., Kuosmanen, S.M., Tong, K.I., Leinonen, H., Woodcock, S.R., Yamamoto, M., Carlberg, C., Yla-Herttuala, S., et al. Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism. J. Biol. Chem. 286 (2011), 14019–14027.
118. Kansanen, E., Kuosmanen, S.M., Leinonen, H., Levonen, A.L., The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 1 (2013), 45–49.
119. Kapeta, S., Chondrogianni, N., Gonos, E.S., Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J. Biol. Chem. 285 (2010), 8171–8184.
120. Karsli-Uzunbas, G., Guo, J.Y., Price, S., Teng, X., Laddha, S.V., Khor, S., Kalaany, N.Y., Jacks, T., Chan, C.S., Rabinowitz, J.D., White, E., Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 4 (2014), 914–927.
121. Kay, H.Y., Kim, W.D., Hwang, S.J., Choi, H.S., Gilroy, R.K., Wan, Y.J., Kim, S.G., Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal. 15 (2011), 2135–2146.
122. Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 89–116.
123. Kepinska, M., Szyller, J., Milnerowicz, H., The influence of oxidative stress induced by iron on telomere length. Environ. Toxicol. Pharmacol. 40 (2015), 931–935.
124. Kerins, M.J., Ooi, A., The roles of NRF2 in modulating cellular iron homeostasis. Antioxid. Redox Signal., 2017, 10.1089/ars.2017.7176.
125. Kim, S.B., Pandita, R.K., Eskiocak, U., Ly, P., Kaisani, A., Kumar, R., Cornelius, C., Wright, W.E., Pandita, T.K., Shay, J.W., Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation. Proc. Natl. Acad. Sci. USA 109 (2012), E2949–E2955.
126. Kim, T.H., Hur, E.G., Kang, S.J., Kim, J.A., Thapa, D., Lee, Y.M., Ku, S.K., Jung, Y., Kwak, M.K., NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res. 71 (2011), 2260–2275.
127. Kimmelman, A.C., White, E., Autophagy and tumor metabolism. Cell Metab. 25 (2017), 1037–1043.
128. Kitteringham, N.R., Abdullah, A., Walsh, J., Randle, L., Jenkins, R.E., Sison, R., Goldring, C.E., Powell, H., Sanderson, C., Williams, S., et al. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J. Proteomics 73 (2010), 1612–1631.
129. Knatko, E.V., Ibbotson, S.H., Zhang, Y., Higgins, M., Fahey, J.W., Talalay, P., Dawe, R.S., Ferguson, J., Huang, J.T., Clarke, R., et al. Nrf2 activation protects against solar-simulated ultraviolet radiation in mice and humans. Cancer Prev. Res. (Phila.) 8 (2015), 475–486.
130. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol 24 (2004), 7130–7139.
131. Kobayashi, E.H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., Yamamoto, M., Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun., 7, 2016, 11624.
132. Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., Yabe-Nishimura, C., Tanaka, E., Kamata, T., ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 18 (2013), 32–41.
133. Kohler, U.A., Kurinna, S., Schwitter, D., Marti, A., Schafer, M., Hellerbrand, C., Speicher, T., Werner, S., Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis. Hepatology 60 (2014), 670–678.
134. Komatsu, M., Ichimura, Y., Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 584 (2010), 1374–1378.
135. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.S., Ueno, I., Sakamoto, A., Tong, K.I., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12 (2010), 213–223.
136. Kong, X., Thimmulappa, R., Kombairaju, P., Biswal, S., NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J. Immunol. 185 (2010), 569–577.
137. Kotlo, K.U., Yehiely, F., Efimova, E., Harasty, H., Hesabi, B., Shchors, K., Einat, P., Rozen, A., Berent, E., Deiss, L.P., Nrf2 is an inhibitor of the Fas pathway as identified by Achilles’ heel method, a new function-based approach to gene identification in human cells. Oncogene 22 (2003), 797–806.
138. Kozakowska, M., Dobrowolska-Glazar, B., Okon, K., Jozkowicz, A., Dobrowolski, Z., Dulak, J., Preliminary analysis of the expression of selected proangiogenic and antioxidant genes and MicroRNAs in patients with non-muscle-invasive bladder cancer. J. Clin. Med., 5, 2016, 10.3390/jcm5030029.
139. Krall, E.B., Wang, B., Munoz, D.M., Ilic, N., Raghavan, S., Niederst, M.J., Yu, K., Ruddy, D.A., Aguirre, A.J., Kim, J.W., et al. KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer. Elife, 6, 2017, 10.7554/eLife.18970.
140. Kroemer, G., Marino, G., Levine, B., Autophagy and the integrated stress response. Mol. Cell 40 (2010), 280–293.
141. Kubben, N., Zhang, W., Wang, L., Voss, T.C., Yang, J., Qu, J., Liu, G.H., Misteli, T., Repression of the antioxidant NRF2 pathway in premature aging. Cell 165 (2016), 1361–1374.
142. Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D.I., Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172 (2004), 989–999.
143. Kwak, M.K., Itoh, K., Yamamoto, M., Sutter, T.R., Kensler, T.W., Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med. 7 (2001), 135–145.
144. Kwak, M.K., Wakabayashi, N., Greenlaw, J.L., Yamamoto, M., Kensler, T.W., Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol. 23 (2003), 8786–8794.
145. Kwak, M.K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., Kensler, T.W., Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278 (2003), 8135–8145.
146. Lau, A., Wang, X.J., Zhao, F., Villeneuve, N.F., Wu, T., Jiang, T., Sun, Z., White, E., Zhang, D.D., A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30 (2010), 3275–3285.
147. Lau, A., Zheng, Y., Tao, S., Wang, H., Whitman, S.A., White, E., Zhang, D.D., Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner. Mol. Cell. Biol. 33 (2013), 2436–2446.
148. Lee, S.B., Sellers, B.N., Denicola, G.M., The regulation of NRF2 by nutrient-responsive signaling and its role in anabolic cancer metabolism. Antioxid. Redox Signal, 2017, 10.1089/ars.2017.7356.
149. Leonard, M.O., Kieran, N.E., Howell, K., Burne, M.J., Varadarajan, R., Dhakshinamoorthy, S., Porter, A.G., O'Farrelly, C., Rabb, H., Taylor, C.T., Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J. 20 (2006), 2624–2626.
150. Li, B., Fu, J., Chen, P., Ge, X., Li, Y., Kuiatse, I., Wang, H., Wang, H., Zhang, X., Orlowski, R.Z., The nuclear factor (Erythroid-derived 2)-like 2 and proteasome maturation protein axis mediate bortezomib resistance in multiple myeloma. J. Biol. Chem. 290 (2015), 29854–29868.
151. Li, J., Lee, J.M., Johnson, J.A., Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J. Biol. Chem. 277 (2002), 388–394.
152. Li, L., Pan, H., Wang, H., Li, X., Bu, X., Wang, Q., Gao, Y., Wen, G., Zhou, Y., Cong, Z., et al. Interplay between VEGF and Nrf2 regulates angiogenesis due to intracranial venous hypertension. Sci. Rep., 6, 2016, 37338.
153. Li, W., Liu, H., Zhou, J.S., Cao, J.F., Zhou, X.B., Choi, A.M., Chen, Z.H., Shen, H.H., Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related factor-2 (Nrf2). J. Biol. Chem. 287 (2012), 20922–20930.
154. Limon-Pacheco, J., Gonsebatt, M.E., The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat. Res. 674 (2009), 137–147.
155. Lin, W.M., Li, Z.G., Blockage of cisplatin-induced autophagy sensitizes cervical cancer cells to cisplatin. Genet. Mol. Res. 14 (2015), 16905–16912.
156. Liotta, L.A., Kohn, E., Anoikis: cancer and the homeless cell. Nature 430 (2004), 973–974.
157. Lisek, K., Walerych, D., Del Sal, G., Mutant p53-Nrf2 axis regulates the proteasome machinery in cancer. Mol. Cell. Oncol., 4, 2017, e1217967.
158. Lister, A., Nedjadi, T., Kitteringham, N.R., Campbell, F., Costello, E., Lloyd, B., Copple, I.M., Williams, S., Owen, A., Neoptolemos, J.P., et al. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol. Cancer, 10, 2011, 37.
159. Liu, X., Sun, K., Wang, H., Dai, Y., Inhibition of autophagy by chloroquine enhances the antitumor efficacy of sorafenib in glioblastoma. Cell. Mol. Neurobiol. 36 (2016), 1197–1208.
160. Livneh, I., Cohen-Kaplan, V., Cohen-Rosenzweig, C., Avni, N., Ciechanover, A., The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death. Cell Res. 26 (2016), 869–885.
161. Lluis, J.M., Buricchi, F., Chiarugi, P., Morales, A., Fernandez-Checa, J.C., Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res. 67 (2007), 7368–7377.
162. Lobet, E., Letesson, J.J., Arnould, T., Mitochondria: a target for bacteria. Biochem. Pharmacol. 94 (2015), 173–185.
163. Lock, R., Kenific, C.M., Leidal, A.M., Salas, E., Debnath, J., Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4 (2014), 466–479.
164. Long, M., Rojo de la Vega, M., Wen, Q., Bharara, M., Jiang, T., Zhang, R., Zhou, S., Wong, P.K., Wondrak, G.T., Zheng, H., Zhang, D.D., An essential role of NRF2 in diabetic wound healing. Diabetes 65 (2016), 780–793.
165. Long, M., Tao, S., Rojo de la Vega, M., Jiang, T., Wen, Q., Park, S.L., Zhang, D.D., Wondrak, G.T., Nrf2-dependent suppression of azoxymethane/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde. Cancer Prev. Res. (Phila.) 8 (2015), 444–454.
166. Ludtmann, M.H., Angelova, P.R., Zhang, Y., Abramov, A.Y., Dinkova-Kostova, A.T., Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457 (2014), 415–424.
167. Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A., Mehta, M., Cheung, K.L., Ganesan, S., Kong, A.N., et al. PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function. Mol. Cell. Biol. 32 (2012), 1506–1517.
168. Ma, Q., Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53 (2013), 401–426.
169. MacLeod, A.K., McMahon, M., Plummer, S.M., Higgins, L.G., Penning, T.M., Igarashi, K., Hayes, J.D., Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30 (2009), 1571–1580.
170. Macleod, K.F., The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system. Nat. Rev. Cancer 8 (2008), 769–781.
171. Malhotra, D., Portales-Casamar, E., Singh, A., Srivastava, S., Arenillas, D., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T.W., Wasserman, W.W., Biswal, S., Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-seq profiling and network analysis. Nucleic Acids Res. 38 (2010), 5718–5734.
172. Marengo, B., Nitti, M., Furfaro, A.L., Colla, R., Ciucis, C.D., Marinari, U.M., Pronzato, M.A., Traverso, N., Domenicotti, C., Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy. Oxid. Med. Cell. Longev., 2016, 2016, 6235641.
173. Maruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., Motojima, K., Ishii, T., Nakane, A., Yamamoto, M., Itoh, K., Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch. Biochem. Biophys. 477 (2008), 139–145.
174. Mathew, R., Karp, C.M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137 (2009), 1062–1075.
175. Mathew, S.T., Bergstrom, P., Hammarsten, O., Repeated Nrf2 stimulation using sulforaphane protects fibroblasts from ionizing radiation. Toxicol. Appl. Pharmacol. 276 (2014), 188–194.
176. Maya-Mendoza, A., Ostrakova, J., Kosar, M., Hall, A., Duskova, P., Mistrik, M., Merchut-Maya, J.M., Hodny, Z., Bartkova, J., Christensen, C., Bartek, J., Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol. Oncol. 9 (2015), 601–616.
177. McMahon, M., Lamont, D.J., Beattie, K.A., Hayes, J.D., Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. USA 107 (2010), 18838–18843.
178. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., Hayes, J.D., Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279 (2004), 31556–31567.
179. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., Hayes, J.D., Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281 (2006), 24756–24768.
180. Meakin, P.J., Chowdhry, S., Sharma, R.S., Ashford, F.B., Walsh, S.V., McCrimmon, R.J., Dinkova-Kostova, A.T., Dillon, J.F., Hayes, J.D., Ashford, M.L., Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol. Cell. Biol. 34 (2014), 3305–3320.
181. Miao, W., Hu, L., Scrivens, P.J., Batist, G., Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes. J. Biol. Chem. 280 (2005), 20340–20348.
182. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., Motohashi, H., Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22 (2012), 66–79.
183. Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
184. Morito, N., Yoh, K., Itoh, K., Hirayama, A., Koyama, A., Yamamoto, M., Takahashi, S., Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene 22 (2003), 9275–9281.
185. Mosser, D.D., Morimoto, R.I., Molecular chaperones and the stress of oncogenesis. Oncogene 23 (2004), 2907–2918.
186. Murakami, S., Motohashi, H., Roles of Nrf2 in cell proliferation and differentiation. Free Radic. Biol. Med. 88 (2015), 168–178.
187. Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
188. Muz, B., de la Puente, P., Azab, F., Azab, A.K., The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl.) 3 (2015), 83–92.
189. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D.L., Schneck, J., Gabrilovich, D.I., Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13 (2007), 828–835.
190. Navon, A., Ciechanover, A., The 26 S proteasome: from basic mechanisms to drug targeting. J. Biol. Chem. 284 (2009), 33713–33718.
191. Negrini, S., Gorgoulis, V.G., Halazonetis, T.D., Genomic instability–an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11 (2010), 220–228.
192. Nepomuceno, T.C., de Gregoriis, G., de Oliveira, F.M.B., Suarez-Kurtz, G., Monteiro, A.N., Carvalho, M.A., The role of PALB2 in the DNA damage response and cancer predisposition. Int. J. Mol. Sci., 18, 2017, 10.3390/ijms18091886.
193. Ni, H.M., Boggess, N., McGill, M.R., Lebofsky, M., Borude, P., Apte, U., Jaeschke, H., Ding, W.X., Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol. Sci. 127 (2012), 438–450.
194. Ni, H.M., Woolbright, B.L., Williams, J., Copple, B., Cui, W., Luyendyk, J.P., Jaeschke, H., Ding, W.X., Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. J. Hepatol. 61 (2014), 617–625.
195. Niforou, K., Cheimonidou, C., Trougakos, I.P., Molecular chaperones and proteostasis regulation during redox imbalance. Redox Biol. 2 (2014), 323–332.
196. Niso-Santano, M., Gonzalez-Polo, R.A., Bravo-San Pedro, J.M., Gomez-Sanchez, R., Lastres-Becker, I., Ortiz-Ortiz, M.A., Soler, G., Moran, J.M., Cuadrado, A., Fuentes, J.M., Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. Free Radic. Biol. Med. 48 (2010), 1370–1381.
197. Niture, S.K., Jaiswal, A.K., Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J. Biol. Chem. 287 (2012), 9873–9886.
198. Niture, S.K., Jaiswal, A.K., Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. Free Radic. Biol. Med. 57 (2013), 119–131.
199. O'Sullivan, T., Saddawi-Konefka, R., Gross, E., Tran, M., Mayfield, S.P., Ikeda, H., Bui, J.D., Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 7 (2014), 989–998.
200. Ogrunc, M., di Micco, R., Liontos, M., Bombardelli, L., Mione, M., Fumagalli, M., Gorgoulis, V.G., D'adda di Fagagna, F., Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 21 (2014), 998–1012.
201. Oh, E.T., Kim, J.W., Kim, J.M., Kim, S.J., Lee, J.S., Hong, S.S., Goodwin, J., Ruthenborg, R.J., Jung, M.G., Lee, H.J., et al. NQO1 inhibits proteasome-mediated degradation of HIF-1alpha. Nat. Commun., 7, 2016, 13593.
202. Oh, S.Y., Sohn, Y.W., Park, J.W., Park, H.J., Jeon, H.M., Kim, T.K., Lee, J.S., Jung, J.E., Jin, X., Chung, Y.G., et al. Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species mediated damage. Mol. Cancer Ther. 6 (2007), 2178–2187.
203. Ono, M., Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 99 (2008), 1501–1506.
204. Osburn, W.O., Wakabayashi, N., Misra, V., Nilles, T., Biswal, S., Trush, M.A., Kensler, T.W., Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch. Biochem. Biophys. 454 (2006), 7–15.
205. Padmanabhan, B., Tong, K.I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.I., Kobayashi, A., Yokoyama, S., Yamamoto, M., Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21 (2006), 689–700.
206. Pajares, M., Jimenez-Moreno, N., Garcia-Yague, A.J., Escoll, M., de Ceballos, M.L., van Leuven, F., Rabano, A., Yamamoto, M., Rojo, A.I., Cuadrado, A., Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy 12 (2016), 1902–1916.
207. Pan, H., Wang, H., Zhu, L., Mao, L., Qiao, L., Su, X., The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg. 80 (2013), 363–370.
208. Panier, S., Boulton, S.J., Double-strand break repair: 53BP1 comes into focus. Nat. Rev. Mol. Cell Biol. 15 (2014), 7–18.
209. Pi, J., Leung, L., Xue, P., Wang, W., Hou, Y., Liu, D., Yehuda-Shnaidman, E., Lee, C., Lau, J., Kurtz, T.W., Chan, J.Y., Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J. Biol. Chem. 285 (2010), 9292–9300.
210. Piantadosi, C.A., Withers, C.M., Bartz, R.R., MacGarvey, N.C., Fu, P., Sweeney, T.E., Welty-Wolf, K.E., Suliman, H.B., Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J. Biol. Chem. 286 (2011), 16374–16385.
211. Popineau, L., Morzyglod, L., Carre, N., Cauzac, M., Bossard, P., Prip-Buus, C., Lenoir, V., Ragazzon, B., Fauveau, V., Robert, L., et al. A novel Grb14-mediated cross-talk between insulin and p62/Nrf2 pathways regulates liver lipogenesis and selective insulin resistance. Mol. Cell. Biol. 36 (2016), 2168–2181.
212. Porta, C., Paglino, C., Mosca, A., Targeting PI3K/Akt/mTOR signaling in cancer. Front. Oncol., 4, 2014, 64.
213. Prestera, T., Holtzclaw, W.D., Zhang, Y., Talalay, P., Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA 90 (1993), 2965–2969.
214. Qiao, S., Lamore, S.D., Cabello, C.M., Lesson, J.L., Munoz-Rodriguez, J.L., Wondrak, G.T., Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem. Pharmacol. 83 (2012), 1229–1240.
215. Qiao, S., Tao, S., Rojo de la Vega, M., Park, S.L., Vonderfecht, A.A., Jacobs, S.L., Zhang, D.D., Wondrak, G.T., The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy 9 (2013), 2087–2102.
216. Rada, P., Rojo, A.I., Chowdhry, S., McMahon, M., Hayes, J.D., Cuadrado, A., SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell. Biol. 31 (2011), 1121–1133.
217. Rada, P., Rojo, A.I., Evrard-Todeschi, N., Innamorato, N.G., Cotte, A., Jaworski, T., Tobon-Velasco, J.C., Devijver, H., Garcia-Mayoral, M.F., van Leuven, F., et al. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/beta-TrCP axis. Mol. Cell. Biol. 32 (2012), 3486–3499.
218. Ramos-Gomez, M., Kwak, M.K., Dolan, P.M., Itoh, K., Yamamoto, M., Talalay, P., Kensler, T.W., Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98 (2001), 3410–3415.
219. Reddy, R.C., Standiford, T.J., Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. Am. J. Respir. Crit. Care Med. 182 (2010), 134–135.
220. Riz, I., Hawley, T.S., Marsal, J.W., Hawley, R.G., Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming. Oncotarget 7 (2016), 66360–66385.
221. Rojo, A.I., Rada, P., Mendiola, M., Ortega-Molina, A., Wojdyla, K., Rogowska-Wrzesinska, A., Hardisson, D., Serrano, M., Cuadrado, A., The PTEN/NRF2 axis promotes human carcinogenesis. Antioxid. Redox Signal. 21 (2014), 2498–2514.
222. Rojo, A.I., Sagarra, M.R., Cuadrado, A., GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J. Neurochem. 105 (2008), 192–202.
223. Romero, R., Sayin, V.I., Davidson, S.M., Bauer, M.R., Singh, S.X., Leboeuf, S.E., Karakousi, T.R., Ellis, D.C., Bhutkar, A., Sanchez-Rivera, F.J., et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat. Med. 23 (2017), 1362–1368.
224. Roy, R., Chun, J., Powell, S.N., BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12 (2011), 68–78.
225. Ruefli-Brasse, A., Reed, J.C., Therapeutics targeting Bcl-2 in hematological malignancies. Biochem. J. 474 (2017), 3643–3657.
226. Ryoo, I.G., Choi, B.H., Kwak, M.K., Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells. Oncotarget 6 (2015), 8167–8184.
227. Ryoo, I.G., Lee, S.H., Kwak, M.K., Redox modulating NRF2: a potential mediator of cancer stem cell resistance. Oxid. Med. Cell. Longev., 2016, 2016, 2428153.
228. Sabharwal, S.S., Schumacker, P.T., Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?. Nat. Rev. Cancer 14 (2014), 709–721.
229. Saddawi-Konefka, R., O'Sullivan, T., Gross, E.T., Washington, A. Jr., Bui, J.D., Tumor-expressed IL-17D recruits NK cells to reject tumors. Oncoimmunology, 3, 2014, e954853.
230. Saddawi-Konefka, R., Seelige, R., Gross, E.T., Levy, E., Searles, S.C., Washington, A. Jr., Santosa, E.K., Liu, B., O'Sullivan, T.E., Harismendy, O., et al. Nrf2 induces IL-17D to mediate tumor and virus surveillance. Cell Rep. 16 (2016), 2348–2358.
231. Saha, T., Rih, J.K., Rosen, E.M., BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett. 583 (2009), 1535–1543.
232. Saibil, H., Chaperone machines for protein folding, unfolding and disaggregation. Nat. Rev. Mol. Cell Biol. 14 (2013), 630–642.
233. Saito, T., Ichimura, Y., Taguchi, K., Suzuki, T., Mizushima, T., Takagi, K., Hirose, Y., Nagahashi, M., Iso, T., Fukutomi, T., et al. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming. Nat. Commun., 7, 2016, 12030.
234. Sakamoto, K., Iwasaki, K., Sugiyama, H., Tsuji, Y., Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications. Mol. Biol. Cell 20 (2009), 1606–1617.
235. Salazar, M., Rojo, A.I., Velasco, D., de Sagarra, R.M., Cuadrado, A., Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J. Biol. Chem. 281 (2006), 14841–14851.
236. Sankaran, V.G., Orkin, S.H., Walkley, C.R., Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 22 (2008), 463–475.
237. Satoh, H., Moriguchi, T., Saigusa, D., Baird, L., Yu, L., Rokutan, H., Igarashi, K., Ebina, M., Shibata, T., Yamamoto, M., NRF2 intensifies host defense systems to prevent lung carcinogenesis, but after tumor initiation accelerates malignant cell growth. Cancer Res. 76 (2016), 3088–3096.
238. Satoh, H., Moriguchi, T., Taguchi, K., Takai, J., Maher, J.M., Suzuki, T., Winnard, P.T. Jr., Raman, V., Ebina, M., Nukiwa, T., et al. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 31 (2010), 1833–1843.
239. Satoh, H., Moriguchi, T., Takai, J., Ebina, M., Yamamoto, M., Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 73 (2013), 4158–4168.
240. Schroder, M., Kaufman, R.J., ER stress and the unfolded protein response. Mutat. Res. 569 (2005), 29–63.
241. Sekhar, K.R., Freeman, M.L., Nrf2 promotes survival following exposure to ionizing radiation. Free Radic. Biol. Med. 88 (2015), 268–274.
242. Serafini, P., Borrello, I., Bronte, V., Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16 (2006), 53–65.
243. Sha, L.K., Sha, W., Kuchler, L., Daiber, A., Giegerich, A.K., Weigert, A., Knape, T., Snodgrass, R., Schroder, K., Brandes, R.P., et al. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability. Free Radic. Biol. Med. 83 (2015), 77–88.
244. Shaulian, E., Karin, M., AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002), E131–E136.
245. Shen, H., Yang, Y., Xia, S., Rao, B., Zhang, J., Wang, J., Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. Dis. Esophagus 27 (2014), 685–692.
246. Shen, T., Jiang, T., Long, M., Chen, J., Ren, D., Wong, P.K., Chapman, E., Zhou, B., Zhang, D.D., A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the Nrf2 protective response. Antioxid. Redox Signal. 23 (2015), 651–664.
247. Shibata, T., Saito, S., Kokubu, A., Suzuki, T., Yamamoto, M., Hirohashi, S., Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway. Cancer Res. 70 (2010), 9095–9105.
248. Shibue, T., Weinberg, R.A., EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14 (2017), 611–629.
249. Shih, A.Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., Murphy, T.H., Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280 (2005), 22925–22936.
250. Shih, P.H., Yen, G.C., Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 8 (2007), 71–80.
251. Shin, S., Wakabayashi, J., Yates, M.S., Wakabayashi, N., Dolan, P.M., Aja, S., Liby, K.T., Sporn, M.B., Yamamoto, M., Kensler, T.W., Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol. 620 (2009), 138–144.
252. Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G.H., Agoston, E.S., Yamamoto, M., Kensler, T.W., NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol. Cell. Biol. 27 (2007), 7188–7197.
253. Singh, A., Happel, C., Manna, S.K., Acquaah-Mensah, G., Carrerero, J., Kumar, S., Nasipuri, P., Krausz, K.W., Wakabayashi, N., Dewi, R., et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J. Clin. Invest. 123 (2013), 2921–2934.
254. Singh, A., Misra, V., Thimmulappa, R.K., Lee, H., Ames, S., Hoque, M.O., Herman, J.G., Baylin, S.B., Sidransky, D., Gabrielson, E., et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med., 3, 2006, e420.
255. Singh, B., Bhat, N.K., Bhat, H.K., Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis 33 (2012), 156–163.
256. Singh, B., Chatterjee, A., Ronghe, A.M., Bhat, N.K., Bhat, H.K., Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer. BMC Cancer, 13, 2013, 253.
257. Soussi, T., Wiman, K.G., TP53: an oncogene in disguise. Cell Death Differ. 22 (2015), 1239–1249.
258. Starheim, K.K., Holien, T., Misund, K., Johansson, I., Baranowska, K.A., Sponaas, A.M., Hella, H., Buene, G., Waage, A., Sundan, A., Bjorkoy, G., Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells. Blood Cancer J., 6, 2016, e446.
259. Stepien, K.M., Heaton, R., Rankin, S., Murphy, A., Bentley, J., Sexton, D., Hargreaves, I.P., Evidence of oxidative stress and secondary mitochondrial dysfunction in metabolic and non-metabolic disorders. J. Clin. Med., 6, 2017, 10.3390/jcm6070071.
260. Stockwell, B.R., Friedmann Angeli, J.P., Bayir, H., Bush, A.I., Conrad, M., Dixon, S.J., Fulda, S., Gascon, S., Hatzios, S.K., Kagan, V.E., et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171 (2017), 273–285.
261. Strandgren, C., Revechon, G., Carvajal, A.S., Eriksson, M., Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome. Biochem. Soc. Trans. 45 (2017), 1279–1293.
262. Strohecker, A.M., Guo, J.Y., Karsli-Uzunbas, G., Price, S.M., Chen, G.J., Mathew, R., McMahon, M., White, E., Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 3 (2013), 1272–1285.
263. Suh, J.H., Shenvi, S.V., Dixon, B.M., Liu, H., Jaiswal, A.K., Liu, R.M., Hagen, T.M., Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. USA 101 (2004), 3381–3386.
264. Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., Tang, D., Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63 (2016), 173–184.
265. Sun, Z., Wu, T., Zhao, F., Lau, A., Birch, C.M., Zhang, D.D., KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response. Mol. Cell. Biol. 31 (2011), 1800–1811.
266. Sun, Z., Zhang, S., Chan, J.Y., Zhang, D.D., Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 27 (2007), 6334–6349.
267. Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S., Nishimura, M., Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 39 (2008), 673–682.
268. Swann, J.B., Smyth, M.J., Immune surveillance of tumors. J. Clin. Invest. 117 (2007), 1137–1146.
269. Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, O., Tanaka, K., Mizushima, N., Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25 (2011), 795–800.
270. Tanaka, Y., Aleksunes, L.M., Yeager, R.L., Gyamfi, M.A., Esterly, N., Guo, G.L., Klaassen, C.D., NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 325 (2008), 655–664.
271. Tao, S., Justiniano, R., Zhang, D.D., Wondrak, G.T., The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV. Redox Biol. 1 (2013), 532–541.
272. Tao, S., Liu, P., Luo, G., Rojo de la Vega, M., Chen, H., Wu, T., Tillotson, J., Chapman, E., Zhang, D.D., p97 negatively regulates NRF2 by extracting ubiquitylated NRF2 from the KEAP1-CUL3 E3 complex. Mol. Cell. Biol., 37, 2017, 10.1128/MCB.00660-16.
273. Tao, S., Park, S.L., Rojo de la Vega, M., Zhang, D.D., Wondrak, G.T., Systemic administration of the apocarotenoid bixin protects skin against solar UV-induced damage through activation of NRF2. Free Radic. Biol. Med. 89 (2015), 690–700.
274. Tao, S., Rojo de la Vega, M., Chapman, E., Ooi, A., Zhang, D.D., The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol. Carcinog. 57 (2017), 182–192.
275. Tao, S., Wang, S., Moghaddam, S.J., Ooi, A., Chapman, E., Wong, P.K., Zhang, D.D., Oncogenic KRAS confers chemoresistance by upregulating NRF2. Cancer Res. 74 (2014), 7430–7441.
276. Tebay, L.E., Robertson, H., Durant, S.T., Vitale, S.R., Penning, T.M., Dinkova-Kostova, A.T., Hayes, J.D., Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic. Biol. Med. 88 (2015), 108–146.
277. Techer, H., Koundrioukoff, S., Nicolas, A., Debatisse, M., The impact of replication stress on replication dynamics and DNA damage in vertebrate cells. Nat. Rev. Genet. 18 (2017), 535–550.
278. Thimmulappa, R.K., Lee, H., Rangasamy, T., Reddy, S.P., Yamamoto, M., Kensler, T.W., Biswal, S., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116 (2006), 984–995.
279. Thimmulappa, R.K., Mai, K.H., Srisuma, S., Kensler, T.W., Yamamoto, M., Biswal, S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62 (2002), 5196–5203.
280. Tong, K.I., Kobayashi, A., Katsuoka, F., Yamamoto, M., Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387 (2006), 1311–1320.
281. Torrente, L., Sanchez, C., Moreno, R., Chowdhry, S., Cabello, P., Isono, K., Koseki, H., Honda, T., Hayes, J.D., Dinkova-Kostova, A.T., de la Vega, L., Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses. Oncogene 36 (2017), 6204–6212.
282. Toth, R.K., Warfel, N.A., Strange bedfellows: nuclear factor, erythroid 2-like 2 (Nrf2) and hypoxia-inducible factor 1 (HIF-1) in tumor hypoxia. Antioxidants (Basel), 6, 2017, 10.3390/antiox6020027.
283. Trachootham, D., Lu, W., Ogasawara, M.A., Nilsa, R.D., Huang, P., Redox regulation of cell survival. Antioxid. Redox Signal. 10 (2008), 1343–1374.
284. Trougakos, I.P., Sesti, F., Tsakiri, E., Gorgoulis, V.G., Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis. J. Proteomics 92 (2013), 274–298.
285. Tung, M.C., Lin, P.L., Wang, Y.C., He, T.Y., Lee, M.C., Yeh, S.D., Chen, C.Y., Lee, H., Mutant p53 confers chemoresistance in non-small-cell lung cancer by upregulating Nrf2. Oncotarget 6 (2015), 41692–41705.
286. Um, H.C., Jang, J.H., Kim, D.H., Lee, C., Surh, Y.J., Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells. Nitric Oxide 25 (2011), 161–168.
287. Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T.W., Yamamoto, M., The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell. Biol. 33 (2013), 2996–3010.
288. Villeneuve, N.F., Sun, Z., Chen, W., Zhang, D.D., Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle 8 (2009), 3255–3256.
289. Vinay, D.S., Ryan, E.P., Pawelec, G., Talib, W.H., Stagg, J., Elkord, E., Lichtor, T., Decker, W.K., Whelan, R.L., Kumara, H.M., et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin. Cancer Biol. 35:Suppl (2015), S185–S198.
290. Volonte, D., Liu, Z., Musille, P.M., Stoppani, E., Wakabayashi, N., Di, Y.P., Lisanti, M.P., Kensler, T.W., Galbiati, F., Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence. Mol. Biol. Cell 24 (2013), 1852–1862.
291. Wagner, P.J., Park, H.R., Wang, Z., Kirchner, R., Wei, Y., Su, L., Stanfield, K., Guilarte, T.R., Wright, R.O., Christiani, D.C., Lu, Q., In vitro effects of lead on gene expression in neural stem cells and associations between up-regulated genes and cognitive scores in children. Environ. Health Perspect. 125 (2017), 721–729.
292. Wakabayashi, N., Shin, S., Slocum, S.L., Agoston, E.S., Wakabayashi, J., Kwak, M.K., Misra, V., Biswal, S., Yamamoto, M., Kensler, T.W., Regulation of notch1 signaling by nrf2: implications for tissue regeneration. Sci. Signal., 3, 2010, ra52.
293. Wakabayashi, N., Skoko, J.J., Chartoumpekis, D.V., Kimura, S., Slocum, S.L., Noda, K., Palliyaguru, D.L., Fujimuro, M., Boley, P.A., Tanaka, Y., et al. Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling. Mol. Cell. Biol. 34 (2014), 653–663.
294. Walerych, D., Lisek, K., Sommaggio, R., Piazza, S., Ciani, Y., Dalla, E., Rajkowska, K., Gaweda-Walerych, K., Ingallina, E., Tonelli, C., et al. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nat. Cell Biol. 18 (2016), 897–909.
295. Wang, H., Liu, X., Long, M., Huang, Y., Zhang, L., Zhang, R., Zheng, Y., Liao, X., Wang, Y., Liao, Q., et al. NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis. Sci. Transl. Med., 8, 2016, 334ra51.
296. Wang, M., Kaufman, R.J., The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer 14 (2014), 581–597.
297. Wang, R., Yu, Z., Sunchu, B., Shoaf, J., Dang, I., Zhao, S., Caples, K., Bradley, L., Beaver, L.M., Ho, E., et al. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Aging Cell 16 (2017), 564–574.
298. Wang, X.J., Hayes, J.D., Wolf, C.R., Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res. 66 (2006), 10983–10994.
299. Wang, X.J., Sun, Z., Villeneuve, N.F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G.T., et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29 (2008), 1235–1243.
300. Warfel, N.A., Sainz, A.G., Song, J.H., Kraft, A.S., PIM kinase inhibitors kill hypoxic tumor cells by reducing Nrf2 signaling and increasing reactive oxygen species. Mol. Cancer Ther. 15 (2016), 1637–1647.
301. Wei, S.J., Botero, A., Hirota, K., Bradbury, C.M., Markovina, S., Laszlo, A., Spitz, D.R., Goswami, P.C., Yodoi, J., Gius, D., Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res. 60 (2000), 6688–6695.
302. Wei, W., Yang, Z., Tang, C.H., Liu, L., Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine. Carcinogenesis 32 (2011), 973–977.
303. White, E., Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12 (2012), 401–410.
304. Whitesell, L., Lindquist, S., Inhibiting the transcription factor HSF1 as an anticancer strategy. Expert Opin. Ther. Targets 13 (2009), 469–478.
305. ∗ induces oxidative stress and DNA damage. J. Virol. 88 (2014), 6751–6761.
306. Wondrak, G.T., Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr. Opin. Investig. Drugs 8 (2007), 390–400.
307. Wondrak, G.T., Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid. Redox Signal. 11 (2009), 3013–3069.
308. Wu, K.C., Cui, J.Y., Klaassen, C.D., Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol. Sci. 123 (2011), 590–600.
309. Wu, T., Harder, B.G., Wong, P.K., Lang, J.E., Zhang, D.D., Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?. Mol. Carcinog. 54 (2015), 1494–1502.
310. Wu, T., Wang, X.J., Tian, W., Jaramillo, M.C., Lau, A., Zhang, D.D., Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. Free Radic. Biol. Med. 67 (2014), 69–80.
311. Wu, T., Zhao, F., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P.K., Chapman, E., Fang, D., Zhang, D.D., Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev. 28 (2014), 708–722.
312. Xu, C., Huang, M.T., Shen, G., Yuan, X., Lin, W., Khor, T.O., Conney, A.H., Kong, A.N., Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 66 (2006), 8293–8296.
313. Xu, C., Li, C.Y., Kong, A.N., Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28 (2005), 249–268.
314. Xu, L., Li, S., Stohr, B.A., The role of telomere biology in cancer. Annu. Rev. Pathol. 8 (2013), 49–78.
315. Xue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M.M., Kitteringham, N., Park, B.K., Souma, T., Moriguchi, T., Yamamoto, M., Thornalley, P.J., Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem. J. 443 (2012), 213–222.
316. Yadav, R.K., Chae, S.W., Kim, H.R., Chae, H.J., Endoplasmic reticulum stress and cancer. J. Cancer Prev. 19 (2014), 75–88.
317. Yamadori, T., Ishii, Y., Homma, S., Morishima, Y., Kurishima, K., Itoh, K., Yamamoto, M., Minami, Y., Noguchi, M., Hizawa, N., Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Oncogene 31 (2012), 4768–4777.
318. Yang, J., Zheng, Z., Yan, X., Li, X., Liu, Z., Ma, Z., Integration of autophagy and anoikis resistance in solid tumors. Anat. Rec. (Hoboken) 296 (2013), 1501–1508.
319. Yang, L., Palliyaguru, D.L., Kensler, T.W., Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. Semin. Oncol. 43 (2016), 146–153.
320. Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J.M., Dell'Antonio, G., et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 25 (2011), 717–729.
321. Yates, M.S., Tran, Q.T., Dolan, P.M., Osburn, W.O., Shin, S., McCulloch, C.C., Silkworth, J.B., Taguchi, K., Yamamoto, M., Williams, C.R., et al. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30 (2009), 1024–1031.
322. Yoon, D.S., Choi, Y., Lee, J.W., Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53-SIRT1 axis. Cell Death Dis., 7, 2016, e2093.
323. You, A., Nam, C.W., Wakabayashi, N., Yamamoto, M., Kensler, T.W., Kwak, M.K., Transcription factor Nrf2 maintains the basal expression of Mdm2: an implication of the regulation of p53 signaling by Nrf2. Arch. Biochem. Biophys. 507 (2011), 356–364.
324. Yuan, X., Zhou, Y., Wang, W., Li, J., Xie, G., Zhao, Y., Xu, D., Shen, L., Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell Death Dis., 4, 2013, e794.
325. Zeeshan, H.M., Lee, G.H., Kim, H.R., Chae, H.J., Endoplasmic reticulum stress and associated ROS. Int. J. Mol. Sci., 17, 2016, 327.
326. Zhang, C., Wang, H.J., Bao, Q.C., Wang, L., Guo, T.K., Chen, W.L., Xu, L.L., Zhou, H.S., Bian, J.L., Yang, Y.R., et al. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction. Oncotarget 7 (2016), 73593–73606.
327. Zhang, D.D., Hannink, M., Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23 (2003), 8137–8151.
328. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J., Hannink, M., Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24 (2004), 10941–10953.
329. Zhang, L., Wang, N., Zhou, S., Ye, W., Jing, G., Zhang, M., Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J. Exp. Clin. Cancer Res., 31, 2012, 66.
330. Zhang, M., Zhang, C., Zhang, L., Yang, Q., Zhou, S., Wen, Q., Wang, J., Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma. BMC Cancer, 15, 2015, 531.
331. Zhang, X., Liang, D., Guo, L., Liang, W., Jiang, Y., Li, H., Zhao, Y., Lu, S., Chi, Z.H., Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Mol. Med. Rep. 12 (2015), 1347–1355.
332. Zhang, Y.K., Wu, K.C., Klaassen, C.D., Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice. PLoS One, 8, 2013, e59122.
333. Zhao, Q., Mao, A., Guo, R., Zhang, L., Yan, J., Sun, C., Tang, J., Ye, Y., Zhang, Y., Zhang, H., Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis. Oncotarget 8 (2017), 36603–36613.
334. Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., Shi, M., ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol. Cancer, 16, 2017, 79.
335. Zhou, W., Mo, X., Cui, W., Zhang, Z., Li, D., Li, L., Xu, L., Yao, H., Gao, J., Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis. Sci. Rep., 6, 2016, 38646.
336. Zhu, J., Wang, H., Fan, Y., Hu, Y., Ji, X., Sun, Q., Liu, H., Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells. Oncol. Rep. 32 (2014), 1170–1178.
337. Zhu, J., Wang, H., Sun, Q., Ji, X., Zhu, L., Cong, Z., Zhou, Y., Liu, H., Zhou, M., Nrf2 is required to maintain the self-renewal of glioma stem cells. BMC Cancer, 13, 2013, 380.
338. Zhu, K., Dunner, K. Jr., McConkey, D.J., Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29 (2010), 451–462.
339. Zhu, M., Fahl, W.E., Functional characterization of transcription regulators that interact with the electrophile response element. Biochem. Biophys. Res. Commun. 289 (2001), 212–219.